Department of Cardiology, Prof. Dr. Cemil Taşçıoğlu City Hospital, İstanbul, Turkey.
Turk Kardiyol Dern Ars. 2022 Oct;50(7):505-511. doi: 10.5543/tkda.2022.22513.
Acute myocardial infarction constitutes one of the leading reasons for cardiac mortality. Therefore, early identification of high-risk patients provides better prognostic accuracy. This study aimed to investigate the prognostic significance of novel inflammatory biomarkers such as neutr ophil -to-l ympho cyte ratio, systemic immune-inflammation index, and prognostic nutritional index in acute myocardial infarction patients treated with percutaneous coronary intervention and to compare their predictive abilities with each other.
A total of 828 acute myocardial infarction patients treated with percutaneous coronary intervention were retrospectively analyzed. The inflammatory indices, such as neutr ophil-to-l ympho cyte ratio, systemic immune-inflammation index, and prognostic nutritional index, were calculated by admission blood tests. The study population was divided into 2 groups according to the occurrence of major adverse cardiac events, which were defined as all-cause mortality, non-fatal myocardial infarction, and cerebrovascular events.
Multivariate Cox regression analysis determined prognostic nutritional index as an independent predictor of major adverse cardiac event and all-cause mortality (hazard ratio: 1.05, 95% CI: 1.02-1.07, P < .001 for major adverse cardiac event and hazard ratio: 1.05, 95% CI: 1.02-1.09, P = .002 for all-cause mortality). Receiver operating characteristic curves revealed that the predictive value of prognostic nutritional index with both regard to major adverse cardiac event and all-cause mortality was better than the systemic immune-inflammation index and neutr ophil -to-l ympho cyte ratio (by DeLong method, area under curvePNI vs. area under curveSII z test = 2.66, P = .008; area under curvePNI vs. area under curveNLR z test = 2.8, P = .006; area under curvePNI vs. area under curveSII z test = 2.58, P = .009; area under curvePNI vs. area under curveNLR z test = 3.28, P = .001; respectively).
Prognostic nutritional index was demonstrated as an independent predictor of major adverse cardiac events and all-cause mortality and a more powerful prognostic index than other novel inflammatory biomarkers in acute myocardial infarction patients treated with percutaneous coronary intervention.
急性心肌梗死是导致心源性死亡的主要原因之一。因此,早期识别高危患者可提供更好的预后准确性。本研究旨在探讨中性粒细胞与淋巴细胞比值、全身免疫炎症指数和预后营养指数等新型炎症标志物在经皮冠状动脉介入治疗的急性心肌梗死患者中的预后意义,并比较它们彼此之间的预测能力。
回顾性分析 828 例经皮冠状动脉介入治疗的急性心肌梗死患者。通过入院时的血液检查计算炎症指标,如中性粒细胞与淋巴细胞比值、全身免疫炎症指数和预后营养指数。根据主要不良心脏事件的发生情况将研究人群分为 2 组,主要不良心脏事件定义为全因死亡率、非致死性心肌梗死和脑血管事件。
多变量 Cox 回归分析确定预后营养指数是主要不良心脏事件和全因死亡率的独立预测因子(危险比:1.05,95%置信区间:1.02-1.07,P <.001 用于主要不良心脏事件;危险比:1.05,95%置信区间:1.02-1.09,P =.002 用于全因死亡率)。受试者工作特征曲线显示,预后营养指数对主要不良心脏事件和全因死亡率的预测价值均优于全身免疫炎症指数和中性粒细胞与淋巴细胞比值(通过 DeLong 方法,PNI 曲线下面积与 SII 曲线下面积 z 检验 = 2.66,P =.008;PNI 曲线下面积与 NLR 曲线下面积 z 检验 = 2.8,P =.006;PNI 曲线下面积与 SII 曲线下面积 z 检验 = 2.58,P =.009;PNI 曲线下面积与 NLR 曲线下面积 z 检验 = 3.28,P =.001)。
预后营养指数被证明是经皮冠状动脉介入治疗的急性心肌梗死患者主要不良心脏事件和全因死亡率的独立预测因子,并且是比其他新型炎症标志物更强大的预后指标。